Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
97 tokens/sec
GPT-4o
53 tokens/sec
Gemini 2.5 Pro Pro
44 tokens/sec
o3 Pro
5 tokens/sec
GPT-4.1 Pro
47 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Toward the automated analysis of complex diseases in genome-wide association studies using genetic programming (1702.01780v1)

Published 6 Feb 2017 in cs.NE, cs.LG, q-bio.QM, and stat.ML

Abstract: Machine learning has been gaining traction in recent years to meet the demand for tools that can efficiently analyze and make sense of the ever-growing databases of biomedical data in health care systems around the world. However, effectively using machine learning methods requires considerable domain expertise, which can be a barrier of entry for bioinformaticians new to computational data science methods. Therefore, off-the-shelf tools that make machine learning more accessible can prove invaluable for bioinformaticians. To this end, we have developed an open source pipeline optimization tool (TPOT-MDR) that uses genetic programming to automatically design machine learning pipelines for bioinformatics studies. In TPOT-MDR, we implement Multifactor Dimensionality Reduction (MDR) as a feature construction method for modeling higher-order feature interactions, and combine it with a new expert knowledge-guided feature selector for large biomedical data sets. We demonstrate TPOT-MDR's capabilities using a combination of simulated and real world data sets from human genetics and find that TPOT-MDR significantly outperforms modern machine learning methods such as logistic regression and eXtreme Gradient Boosting (XGBoost). We further analyze the best pipeline discovered by TPOT-MDR for a real world problem and highlight TPOT-MDR's ability to produce a high-accuracy solution that is also easily interpretable.

User Edit Pencil Streamline Icon: https://streamlinehq.com
Authors (3)
  1. Andrew Sohn (3 papers)
  2. Randal S. Olson (19 papers)
  3. Jason H. Moore (56 papers)
Citations (22)

Summary

We haven't generated a summary for this paper yet.